methotrexate has been researched along with Periphlebitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saxena, S | 1 |
| Ajani, JA; Blumenschein, GR; Buzdar, AU; Hortobagyi, GN; Legha, SS | 1 |
| Crumbley, AJ; Grady, CK; Grady, ED; Nolan, TR | 1 |
3 other study(ies) available for methotrexate and Periphlebitis
| Article | Year |
|---|---|
Combined oral corticosteroid-methotrexate therapy in Eales' disease.
Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Phlebitis; Prospective Studies; Retinal Diseases; Time Factors; Treatment Outcome; Visual Acuity; Young Adult | 2009 |
Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Eruptions; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Nausea; Peptichemio; Phlebitis; Thiotepa; Time Factors; Vomiting | 1984 |
Chemotherapy and radiation therapy together to treat cancer.
Topics: Antineoplastic Agents; Cell Division; Cyclophosphamide; DNA, Neoplasm; Female; Fluorouracil; Heparin; Humans; Hyperbaric Oxygenation; Injections, Intra-Arterial; Injections, Intravenous; Male; Methotrexate; Neoplasms; Nitrogen; Oxygen; Perfusion; Phlebitis; Therapeutic Irrigation; Thiotepa; Time Factors; Vinblastine | 1970 |